Skip to main content
Clinical Trials/TCTR20201013004
TCTR20201013004Recruiting未知

Three-times-weekly vs Daily Iron Supplementation for primary prevention of Anemia in Pregnancy Living in Urban Area; An open-label, Randomized Controlled Trial

none0 sites136 target enrollmentStarted: October 13, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
136

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 50 Years (—)
Sex
Female

Inclusion Criteria

  • - Age >= 18 year-old
  • - singleton
  • - < 14 week gestational age
  • - Hb >= 11 mg/dL, mcv >= 80, DCIP - negative
  • - no thyroid disorder
  • - no history of Triferdine allergy
  • - understand and well-communicate Thai

Exclusion Criteria

  • - previous iron supplement in this pregnancy
  • - previous blood transfusion
  • - abnormal bleeding from any sites
  • - thalassemia traits/disease or thyroid disorder
  • - smoking or chronic lung disease
  • - iron, iodine or folic acid allergy
  • - poor compliance
  • - aborted or delivered before 28 week-gestation
  • - Forgot to take Triferdine more than 80%

Investigators

Sponsor
none

Similar Trials